Oberweis Asset Management Inc Veracyte, Inc. Transaction History

Oberweis Asset Management Inc

$1.34 Billion
Q1 2024

A detailed history of Oberweis Asset Management Inc transactions in Veracyte, Inc. stock. As of the latest transaction made, Oberweis Asset Management Inc holds 671,700 shares of VCYT stock, worth $14.3 Million. This represents 1.11% of its overall portfolio holdings.

Number of Shares

671,700

Previous 656,810 2.27%

Holding current value

$14.3 Million

Previous $18.1 Million 17.62%

% of portfolio

1.11%

Previous 1.73%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$21.0 - $29.1 $312,690 - $433,299	14,890 Added 2.27%	671,700 $14.9 Million
Q4 2023 Feb 14, 2024	BUY	$19.72 - $28.68 $1.17 Million - $1.7 Million	59,270 Added 9.92%	656,810 $18.1 Million
Q3 2023 Nov 14, 2023	BUY	$22.33 - $29.92 $2.57 Million - $3.45 Million	115,230 Added 23.89%	597,540 $13.3 Million
Q2 2023 Aug 14, 2023	BUY	$20.96 - $26.99 $5.66 Million - $7.29 Million	270,130 Added 127.31%	482,310 $12.3 Million
Q1 2023 May 15, 2023	BUY	$20.58 - $27.89 $2.47 Million - $3.34 Million	119,780 Added 129.63%	212,180 $4.73 Million

Q4 2022 Feb 14, 2023	BUY	$15.31 - $29.94 $1.41 Million - $2.77 Million	92,400 New	92,400 $2.19 Million
Q4 2019 Feb 14, 2020	SELL	$20.78 - $29.99 $467,550 - $674,775	-22,500 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$23.87 - $30.93 $150,381 - $194,859	-6,300 Reduced 21.88%	22,500 $540,000
Q2 2019 Aug 14, 2019	SELL	$22.1 - $28.56 $236,470 - $305,592	-10,700 Reduced 27.09%	28,800 $821,000
Q1 2019 May 15, 2019	SELL	$12.0 - $25.76 $956,400 - $2.05 Million	-79,700 Reduced 66.86%	39,500 $988,000
Q4 2018 Feb 14, 2019	BUY	$9.15 - $14.85 $290,055 - $470,745	31,700 Added 36.23%	119,200 $1.5 Million
Q3 2018 Nov 14, 2018	BUY	$9.55 - $12.64 $835,625 - $1.11 Million	87,500 New	87,500 $836,000

Others Institutions Holding VCYT

# of Institutions

257

Shares Held

81.7M

Call Options Held

43K

Put Options Held

82K

View Full List

About VERACYTE, INC.

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $1.52B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

More about VCYT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oberweis Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oberweis Asset Management Inc with notifications on news.

Account

Oberweis Asset Management Inc Veracyte, Inc. Transaction History